PDCD1 and colorectal carcinoma: Accordingly, the genetic ablation of PD-L1 increases PD-1+ TAM phagocytosis in vivo, inhibits tumor growth, and improves the survival of CRC-bearing mice in a macrophage-dependent manner [197].